11,973
Participants
Start Date
June 18, 2020
Primary Completion Date
January 31, 2022
Study Completion Date
January 31, 2022
Data Collection
"DATA COLLECTION AT ENROLLMENT:~Demographics; Symptoms and health status; Co-morbidities; Targeted medications; Specimen Collection (substudy at selected sites): Upper respiratory swab, blood for serum storage.~DATA COLLECTION AT DAYS 7, 14 \& 28:~Vital and hospitalization status; Symptoms and health status"
Denver Public Health, Denver
Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires
CHIP Department of Infectious Diseases, Copenhagen
University College London Medical School Centre for Sexual Health and HIV Research, London
National Institutes of Health (NIH)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Minnesota
OTHER